Thus, ovarian cancer with reduced E-cadherin expression had a higher risk of mortality, but significant heterogeneity (I2 = 57.0%, p = 0.003) was observed across the studies, then random effect model was used. Here, CDH1 is linked to ovarian carcinoma.